Justine Sever Chilelli, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2128 Chamber Center Dr., Lakeside Park, KY 41017 Phone: 859-331-6525 Fax: 859-331-6526 |
News Archive
If detected early, nonmelanoma skin cancers (primarily basal cell and squamous cell carcinomas, the two most common forms of skin cancer) can be easily treated. But when left untreated, these skin cancers can grow and even spread, causing considerably more harm than if they were treated upon initial detection. Now, a new study finds that denial is the top reason why patients delay seeking treatment for skin cancer and shows that this delay results in larger, more serious, skin cancers.
A new study from Australia's national science agency, CSIRO, and the University of Queensland provides further evidence that wastewater (untreated sewage) testing can detect COVID-19 in communities weeks before people display symptoms, suggesting this testing could provide a targeted early detection system as economies re-open and people become more mobile.
Testing cancers for 'addiction' to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced a new method for detecting antibody levels in individual patients treated with infliximab, a biologic therapy that has been used to treat more than a million patients across a number of autoimmune diseases, including rheumatoid arthritis, Crohn's disease and ulcerative colitis.
Kylene Kehn-Hall, Associate Professor/Associate Director, School of Systems Biology, National Center for Biodefense and Infectious Diseases, is working to rapidly test and deploy a universal virus enrichment tool that can be used to enhance the detection of SARS-CoV-2 (COVID-19) for any type of diagnostic assay under development, thereby reducing false negatives and the risk of worldwide pandemic.
› Verified 7 days ago